GB202001896D0 - Treatment and prevention of metabolic diseases - Google Patents
Treatment and prevention of metabolic diseasesInfo
- Publication number
- GB202001896D0 GB202001896D0 GBGB2001896.6A GB202001896A GB202001896D0 GB 202001896 D0 GB202001896 D0 GB 202001896D0 GB 202001896 A GB202001896 A GB 202001896A GB 202001896 D0 GB202001896 D0 GB 202001896D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- prevention
- treatment
- metabolic diseases
- metabolic
- diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2001896.6A GB202001896D0 (en) | 2020-02-12 | 2020-02-12 | Treatment and prevention of metabolic diseases |
TW109114711A TW202108606A (en) | 2019-05-03 | 2020-05-01 | Treatment and prevention of metabolic diseases |
US16/865,259 US11813311B2 (en) | 2019-05-03 | 2020-05-01 | Treatment and prevention of metabolic diseases |
PCT/EP2020/062193 WO2020225147A1 (en) | 2019-05-03 | 2020-05-01 | Treatment and prevention of metabolic diseases |
BR112021021921A BR112021021921A2 (en) | 2019-05-03 | 2020-05-01 | Agent, use of an agent and method of treating or preventing a metabolic disease |
JP2021564913A JP2022531591A (en) | 2019-05-03 | 2020-05-01 | Treatment and prevention of metabolic disorders |
EP20721644.1A EP3962936A1 (en) | 2019-05-03 | 2020-05-01 | Treatment and prevention of metabolic diseases |
MX2021013356A MX2021013356A (en) | 2019-05-03 | 2020-05-01 | Treatment and prevention of metabolic diseases. |
CA3146344A CA3146344A1 (en) | 2019-05-03 | 2020-05-01 | Treatment and prevention of metabolic diseases |
AU2020268619A AU2020268619A1 (en) | 2019-05-03 | 2020-05-01 | Treatment and prevention of metabolic diseases |
CN202080049108.3A CN114364693A (en) | 2019-05-03 | 2020-05-01 | Treatment and prevention of metabolic disorders |
KR1020217039250A KR20220050087A (en) | 2019-05-03 | 2020-05-01 | Treatment and prevention of metabolic diseases |
CL2021002878A CL2021002878A1 (en) | 2019-05-03 | 2021-11-02 | Treatment and prevention of metabolic diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2001896.6A GB202001896D0 (en) | 2020-02-12 | 2020-02-12 | Treatment and prevention of metabolic diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202001896D0 true GB202001896D0 (en) | 2020-03-25 |
Family
ID=69897115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2001896.6A Ceased GB202001896D0 (en) | 2019-05-03 | 2020-02-12 | Treatment and prevention of metabolic diseases |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202001896D0 (en) |
-
2020
- 2020-02-12 GB GBGB2001896.6A patent/GB202001896D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3920923A4 (en) | Therapeutic agents and methods of treatment | |
EP3749264C0 (en) | Laser therapy for treatment and prevention of eye diseases | |
EP4119156A4 (en) | Medicament for treatment and/or prevention of cancer | |
EP4090658A4 (en) | Therapeutic agents and methods of treatment | |
IL280315A (en) | Methods of treatment and prevention of alzheimer's disease | |
EP4054713A4 (en) | Compositions and methods for treatment or prevention of skin diseases and disorders with lekti | |
IL287802A (en) | Compositions and methods for treatment of ocular diseases | |
EP4058037A4 (en) | Fibroblast-based therapy for treatment and prevention of stroke | |
IL275925A (en) | Prevention and treatment of organ fibrosis | |
IL272253A (en) | Compositions and methods for treatment of inflammatory conditions and diseases of the skin | |
IL304628A (en) | Treatment of skin disorders | |
GB202002030D0 (en) | Treatment and prevention of metabolic diseases | |
GB202001896D0 (en) | Treatment and prevention of metabolic diseases | |
GB202001013D0 (en) | Treatment and prevention of metabolic diseases | |
EP4099997A4 (en) | Methods and compositions for treatment of diseases | |
GB201906597D0 (en) | Treatment and prevention of metabolic diseases | |
EP4119160A4 (en) | Medicament for treatment and/or prevention of cancer | |
EP4119158A4 (en) | Medicament for treatment and/or prevention of cancer | |
EP4119157A4 (en) | Medicament for treatment and/or prevention of cancer | |
EP4119159A4 (en) | Medicament for treatment and/or prevention of cancer | |
IL270306A (en) | Prevention and treatment of pre-myeloid and myeloid malignancies | |
EP3908370A4 (en) | Use of photobiomodulation therapy to treat inflammatory and/or metabolic conditions | |
EP3863621A4 (en) | Combination therapy for treatment and prevention of autoimmune and inflammatory diseases | |
IL309317A (en) | Treatment of mtres1 related diseases and disorders | |
EP4046658A4 (en) | Application of non-igf1r-binding substance in prevention and/or treatment of inflammatory diseases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |